X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with ALEMBIC LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA ALEMBIC LTD SHASUN PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 123.9 61.1 202.7% View Chart
P/BV x 8.5 2.6 334.3% View Chart
Dividend Yield % 0.2 0.4 58.4%  

Financials

 SHASUN PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
ALEMBIC LTD
Mar-18
SHASUN PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs9472 130.8%   
Low Rs4634 134.5%   
Sales per share (Unadj.) Rs214.24.7 4,556.4%  
Earnings per share (Unadj.) Rs5.36.1 87.4%  
Cash flow per share (Unadj.) Rs15.86.2 253.3%  
Dividends per share (Unadj.) Rs1.000.20 500.0%  
Dividend yield (eoy) %1.40.4 378.8%  
Book value per share (Unadj.) Rs53.340.7 131.2%  
Shares outstanding (eoy) m56.62267.03 21.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.311.3 2.9%   
Avg P/E ratio x13.18.7 151.0%  
P/CF ratio (eoy) x4.48.5 52.1%  
Price / Book Value ratio x1.31.3 100.6%  
Dividend payout %18.73.3 571.9%   
Avg Mkt Cap Rs m3,95814,139 28.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,164207 1,043.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,1271,255 966.1%  
Other income Rs m229370 62.0%   
Total revenues Rs m12,3561,625 760.2%   
Gross profit Rs m1,009111 908.2%  
Depreciation Rs m59438 1,570.4%   
Interest Rs m4152 24,417.6%   
Profit before tax Rs m230442 52.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m01,212 -0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-7324 -303.6%   
Profit after tax Rs m3021,630 18.5%  
Gross profit margin %8.38.9 94.0%  
Effective tax rate %-31.75.4 -584.0%   
Net profit margin %2.5129.8 1.9%  
BALANCE SHEET DATA
Current assets Rs m6,8841,867 368.7%   
Current liabilities Rs m8,456591 1,430.3%   
Net working cap to sales %-13.0101.6 -12.7%  
Current ratio x0.83.2 25.8%  
Inventory Days Days6294 65.4%  
Debtors Days Days10874 146.2%  
Net fixed assets Rs m4,9701,791 277.5%   
Share capital Rs m113534 21.2%   
"Free" reserves Rs m2,87510,324 27.8%   
Net worth Rs m3,02010,858 27.8%   
Long term debt Rs m1,81741 4,411.2%   
Total assets Rs m13,34711,591 115.2%  
Interest coverage x1.6260.9 0.6%   
Debt to equity ratio x0.60 15,858.3%  
Sales to assets ratio x0.90.1 839.0%   
Return on assets %5.414.1 38.2%  
Return on equity %10.015.0 66.6%  
Return on capital %13.315.2 87.7%  
Exports to sales %46.41.5 2,999.3%   
Imports to sales %14.221.0 67.9%   
Exports (fob) Rs m5,62219 28,976.8%   
Imports (cif) Rs m1,728263 656.1%   
Fx inflow Rs m5,84319 30,116.5%   
Fx outflow Rs m2,173264 823.7%   
Net fx Rs m3,669-244 -1,501.3%   
CASH FLOW
From Operations Rs m398236 168.6%  
From Investments Rs m-1,635-224 729.9%  
From Financial Activity Rs m1,309-27 -4,919.5%  
Net Cashflow Rs m71-15 -481.1%  

Share Holding

Indian Promoters % 39.2 64.0 61.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 0.2 1,800.0%  
FIIs % 17.6 9.7 181.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 26.1 151.7%  
Shareholders   20,750 54,701 37.9%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   AUROBINDO PHARMA  DR. REDDYS LAB  NOVARTIS  TTK HEALTHCARE  MERCK LTD  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 290 Points; Realty and PSU Stocks Witness Selling(Closing)

After opening the day on a negative note, share markets in India continued their downtrend throughout the day and ended in red.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY18); Net Profit Up 64.9% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, ALEMBIC LTD has posted a net profit of Rs 46 m (up 64.9% YoY). Sales on the other hand came in at Rs 332 m (up 0.9% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

In a Crisis, if Petrol Prices Hit Rs 100, This Stock Could Be a Good Buy(The 5 Minute Wrapup)

Sep 6, 2018

The rise in the crude oil price is a major reason for the fall in the market. If crude oil prices keep on rising, what will happen to stocks?

As the Rupee Takes a Record Plunge, These Pharma Stocks Gain the Most(Sector Info)

Sep 5, 2018

Most pharma stocks were trading with gains amid rupee's fresh fall. Does that mean pharma stocks are back in vogue?

Why Arun Jaitley's Demonetisation Defence Doesn't Add Up(Vivek Kaul's Diary)

Sep 5, 2018

The tax collected has gone up a little but the question is at what cost.

The Cream of Small Cap Stocks(Profit Hunter)

Sep 5, 2018

Akin to skimming the cream off milk, one needs to learn to skim the cream off small cap stocks.

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - DISHMAN PHARMA COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS